Earnings Labs
VistaGen Therapeutics, Inc. logo

VistaGen Therapeutics, Inc. (VTGN)

NASDAQ·Healthcare·Biotechnology

$0.60

+4.38%

Mkt Cap $18.72M

Analyst Ratings

Buy

0

Hold

2

Sell

0

Price Target (4 analysts)

$0.95

Range $0.90$1.00

Implied Upside

+59.3%

Consensus $0.95 vs current $0.60